Key terms used to carry out the search included “SGLT2 inhibitors,” “glucose,” “diabetes,” “chronic kidney disease,” and “cardiovascular outcomes.” The reference lists of all the included studies were also manually searched for possible inclusion. The gene discussed is SLC5A2; the disease is diabetes mellitus.